Marginal Effects of Public Health Measures and COVID-19 Disease Burden in China: A Large-Scale Modelling Study.
Zengmiao Wang,Peiyi Wu,Lin Wang,Bingying Li,Yonghong Liu,Yuxi Ge,Ruixue Wang,Ligui Wang,Hua Tan,Chieh-Hsi Wu,Marko Laine,Henrik Salje,Hongbin Song
DOI: https://doi.org/10.1371/journal.pcbi.1011492
2023-01-01
PLoS Computational Biology
Abstract:China had conducted some of the most stringent public health measures to control the spread of successive SARS-CoV-2 variants. However, the effectiveness of these measures and their impacts on the associated disease burden have rarely been quantitatively assessed at the national level. To address this gap, we developed a stochastic age-stratified metapopulation model that incorporates testing, contact tracing and isolation, based on 419 million travel movements among 366 Chinese cities. The study period for this model began from September 2022. The COVID-19 disease burden was evaluated, considering 8 types of underlying health conditions in the Chinese population. We identified the marginal effects between the testing speed and reduction in the epidemic duration. The findings suggest that assuming a vaccine coverage of 89%, the Omicron-like wave could be suppressed by 3-day interval population-level testing (PLT), while it would become endemic with 4-day interval PLT, and without testing, it would result in an epidemic. PLT conducted every 3 days would not only eliminate infections but also keep hospital bed occupancy at less than 29.46% (95% CI, 22.73-38.68%) of capacity for respiratory illness and ICU bed occupancy at less than 58.94% (95% CI, 45.70-76.90%) during an outbreak. Furthermore, the underlying health conditions would lead to an extra 2.35 (95% CI, 1.89-2.92) million hospital admissions and 0.16 (95% CI, 0.13-0.2) million ICU admissions. Our study provides insights into health preparedness to balance the disease burden and sustainability for a country with a population of billions. As China continues to be challenged by successive SARS-CoV-2 variants, rethinking population health, broader than health-care system alone, is a prerequisite for health preparedness. China has introduced several changes to its public health measures in response to evolving pandemic risk, however, the effectiveness of public health measures in controlling COVID-19 outbreaks in China and their impacts on the associated disease burden have not been quantitatively assessed at the national level. Here, we developed a stochastic age-stratified metapopulation model based on high resolution human mobility data to address these questions. Our results suggest that there's marginal effects between the testing speed and reduction in the epidemic duration. With a rapid implementation of population-level testing and a short response lag would be critical if aiming at suppression of potential future SARS-CoV-2 waves in China. Furthermore, the underlying health conditions would lead to extra hospital admissions and ICU admissions, where obesity is expected to contribute to most extra hospital admissions, while hypertension could contribute to most extra ICU admissions.